Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of HES 130/0.4 on coagulation after off-pump coronary artery surgery
2007-004424-20Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Oct 2007
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Volulyte in coronary arteriosclerosis, sponsored by Helsinki University Hospital. Primary endpoint: Coagulation assessed by thromboelastography. Started Oct 2007; status: completed.
02
Drugs
Volulyte
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-004424-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004424-20.